Navigation Links
PhRMA, Families USA Jointly Promote Measures to Ensure Quality, Affordable Healthcare Coverage
Date:4/21/2009

WASHINGTON, April 21 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) and the national consumer health organization Families USA today unveiled a campaign to promote three key policies designed to help achieve high-quality, affordable health coverage for all Americans.

PhRMA and Families USA will work together and will reach out to other stakeholders to ensure that these policies are incorporated in the healthcare reform proposals to be considered this year. The two groups' efforts will include an advertising campaign and grassroots mobilization.

"Although our views do not always converge, we share a common belief about a fundamental goal of healthcare reform: Every American deserves high-quality, affordable health coverage and care," said PhRMA President and CEO Billy Tauzin and Families USA Executive Director Ron Pollack.

With this goal in mind, PhRMA and Families USA have partnered together to promote three essential elements of healthcare reform.

First, the two organizations will promote the establishment of a nationwide Medicaid eligibility floor at 133 percent of the federal poverty level -- almost $24,400 in annual income for a family of three. In 43 states, childless adults are currently ineligible for Medicaid even if they are literally penniless.

Second, we propose providing sliding-scale subsidies to moderate-income people who earn too much money to qualify for Medicaid but can't afford insurance premiums. Such subsidies are crucial for the purchase of healthcare in a reformed insurance market. A similar system exists today in Massachusetts.

Third, PhRMA and Families USA will seek a meaningful cap on out-of-pocket health expenditures so that no family is unable to afford essential care. This will also protect families against bankruptcy due to their need for major care.

In tandem with t
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America; Families USA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Families Embrace Science/Technology-based Ancestry Tracing Marking Milestone in Black Family Reunion Celebrations Across the Nation
2. Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy
3. Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug
4. Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement
5. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
6. Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD
7. Pathway for Biosimilars Act Protects Patients, Promotes Competition, Preserves Innovation and Creates Quality Jobs, Lilly Says
8. Dr. Paul Korner Promoted to Senior Vice President of Ferring International PharmaScience Center U.S.
9. Merrimack Pharmaceuticals Promotes Ulrik B. Nielsen, Ph.D. to Chief Scientific Officer and Edward J. Stewart to Senior Vice President of Business Development
10. BioStorage Technologies, Inc. Promotes Lori Ball to Senior Vice President and Expands Role
11. Sirion Therapeutics Partners With Advanced Vision Research (TheraTears(R)) to Promote Products for Retinal and Meibomian Gland Health

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009).... 6 Intarcia Therapeutics, Inc. de...UROS® continuous delivery of exenatide) progr...th Annual Diabetes Technology Meeting in San Franc...-bin/prnh/20050301/SFTU126LOGO ) ,, Continuou...Lowers Plasma Glucose, HbA1c and Reduces Weight in...
(Date:11/5/2009)...ov. 5 GenVec, Inc. (Nasd...for the third quarter ended September 30, 2009. Ge...r share) for the three months ended September 30, ... per share) in the comparable quarter of 2008. For...s net loss was $14.1 million ($0.15 per share), co...
(Date:11/5/2009)...RNewswire-FirstCall/ -- Imagenetix, Inc. (OTC Bull...encer, President and CEO of Imagenetix, will be pr...MICRO Conference on Thursday, December 3rd, at 10:... About LD MICRO ,, LD MICRO is a by-invitation ...valued companies in the micro-cap space. Since 200...
(Date:11/5/2009)... Transgenomic, Inc. (OTC ...sults for the quarter ended September 30, 2009. Th... tables that follow. ,, Third Quarter 2009 ,... $0.01 per share for the third quarter of 2009 as ...are for the third quarter of 2008. ,, Net sale...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...ied for A1c testing using dried blood spot,specime...nternational LLC, a division of Hooper Holmes (Ame...emoglobin A1c testing methods by the National,Glyc...tage Labs uses two blood testing methods for hemog...nd the other for testing dried blood,spots (DBS), ...
...Nov. 11 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIG...esident and chief executive officer, will present ...hcare Conference on Thursday,November 13 at 4:30 p...a,Biltmore Resort in Phoenix, Arizona., To access... recording,log on to http://www.rigel.com . Pleas...
...hera Pharmaceuticals, Inc.,a privately held biopha...rugs, today announced new data on its lead product...ation (AHA) Annual Conference in New Orleans,Louis... varespladib for the,treatment of coronary heart d...laborators released new data from the Phase II PLA...
Other Biology Technology:Heritage Labs Announces A1c Test Certification Milestone 2Heritage Labs Announces A1c Test Certification Milestone 3Anthera's Varespladib Demonstrates Significant Anti-Inflammatory Effect and LDL Reduction in Patients With Coronary Heart Disease 2
(Date:11/4/2009)...n has received more than $10 million in research g...deral stimulus program, bringing thetotal amount o...23 million. Thirty-three projects achieved stimul... weather. , "The university has thoughtfully und...scholarly excellence to federal agency priorities....
(Date:11/4/2009)...e/ -- What,s the cost of saving a teenage life? Wh...ng from prescription medication abuse, there,s no ...may be unaware that the lock-boxes they,ve install... timebomb of prescription drugs. That,s why MEDNET... supplies, has formed an exclusive partnership wit...
(Date:11/4/2009)...swire/ -- GenVault Corporation (Carlsbad, CA) toda...oined its Board of Directors. Dr. Brody, the Irwi... is an acclaimed physician-scientist and universit.... Brody served as president of The Johns Hopkins U... of Engineering and the Institute of Medicine, and...
Breaking Biology News(10 mins):OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Sinovac Adjourns 2008 Annual General Meeting 13056 1Sinovac Adjourns 2008 Annual General Meeting 13056 2AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease 51870 1AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease 51870 2AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease 51870 3Tennis Elbow Shin Splints and Carpal Tunnel Syndrome Could Be a Thing of the Past Due to New Efforts with Sports Musculoskeletal Ultrasound 51869 1Tennis Elbow Shin Splints and Carpal Tunnel Syndrome Could Be a Thing of the Past Due to New Efforts with Sports Musculoskeletal Ultrasound 51869 2Tennis Elbow Shin Splints and Carpal Tunnel Syndrome Could Be a Thing of the Past Due to New Efforts with Sports Musculoskeletal Ultrasound 51869 3Tennis Elbow Shin Splints and Carpal Tunnel Syndrome Could Be a Thing of the Past Due to New Efforts with Sports Musculoskeletal Ultrasound 51869 4
...rking lots may look better with a layer of sealcoa...ff the surface into nearby streams will be carryin...w research conducted at the University of New Hamp...lcoat may contribute to increasingly significant a...ways from stormwater runoff. , Polyaromatic hydro...
...gene that controls the rapid production and differ... cell types -- a discovery that could eventually o...ukemia and other blood cancers, in which blood cel...n investigating the mechanisms of this gene, the s...protocol for bone marrow transplants that could bo...
...es for capitalizing on environmentally friendly fa...l waste to produce jobs, economic growth, commerci...cording to a perspective article published in the ...vate Law . , Ronald Griffin, Professor of Law at ... leaders do for a desperate and aging population i...
Other Biology News:UNH: Pavement sealcoat a source of toxins in stormwater runoff 2Scientists identify key gene that protects against leukemia 2Scientists identify key gene that protects against leukemia 3Ma and Pa solutions to global warming 2
...aging and analysis system is an integrated hardwar...pid acquisition and analysis of fluorescence image...Xpress is fast. Scanning an entire 384-well plate ...fluorescence images per well, takes less than 13 m...
Earle's Balanced Salt Solution, 10x (EBSS) from Sigma-Aldrich
...lined immunospot) Kit analyzes interferon gamma (I...spot forms at the site where secreted cytokine is ...scope or automated ELISPOT reader) and then compar... This allows the frequency of cells secreting the ...
Corning Roller Bottle Easy Grip Caps, Sterile from Sigma-Aldrich
Biology Products: